No approved therapy exists for this Ebola strain.

Approved Ebola treatments target only the Zaire species, leaving Bundibugyo, behind the current outbreak, without any authorized drug.

Jean-Jacques Muyembe, DRC’s leading Ebola scientist, says a monoclonal antibody against Bundibugyo is now in development, no timeline given.

Sources: SciDev.Net